NATIONAL HEALTHCARE CORP
NHCUS売上高
$1.5B
百万USD
営業利益
$128M
百万USD
純利益
$120M
百万USD
ROE
11.2%
最新FY
EPS
$7.67
USD / 株
配当
$2.53
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $251M | $21M | $1.38 |
| FY2021 | Q2 | $263M | $105M | $6.80 |
| FY2021 | Q3 | $277M | $-3M | $-0.22 |
| FY2021 | FY | $1.1B | $139M | $8.99 |
| FY2022 | Q1 | $279M | $15M | $0.99 |
| FY2022 | Q2 | $271M | $3M | $0.21 |
| FY2022 | Q3 | $271M | $-2M | $-0.16 |
| FY2022 | FY | $1.1B | $22M | $1.45 |
| FY2023 | Q1 | $270M | $12M | $0.76 |
| FY2023 | Q2 | $283M | $16M | $1.06 |
| FY2023 | Q3 | $288M | $10M | $0.68 |
| FY2023 | FY | $1.1B | $67M | $4.34 |
| FY2024 | Q1 | $297M | $26M | $1.69 |
| FY2024 | Q2 | $301M | $27M | $1.73 |
| FY2024 | Q3 | $340M | $43M | $2.73 |
| FY2024 | FY | $1.3B | $102M | $6.53 |
| FY2025 | Q1 | $374M | $32M | $2.07 |
| FY2025 | Q2 | $375M | $24M | $1.52 |
| FY2025 | Q3 | $383M | $39M | $2.50 |
| FY2025 | FY | $1.5B | $120M | $7.67 |
| FY2026 | Q1 | $382M | $36M | $2.27 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $980M | $996M | $1.0B | $1.1B | $1.1B | $1.1B | $1.3B | $1.5B |
| 営業利益 | $61M | $54M | $56M | $49M | $48M | $51M | $32M | $57M | $86M | $128M |
| 純利益 | $51M | $56M | $59M | $68M | $42M | $139M | $22M | $67M | $102M | $120M |
| 総資産 | $1.1B | $1.1B | $1.1B | $1.3B | $1.4B | $1.4B | $1.3B | $1.3B | $1.5B | $1.5B |
| 純資産 | - | $703M | $734M | $779M | $798M | $908M | $878M | $910M | $983M | $1.1B |
| 自己資本 | $670M | $703M | $733M | $779M | $795M | $903M | $874M | $909M | $980M | $1.1B |
| 営業CF | - | $94M | $98M | $100M | $203M | $62M | $9M | $111M | $107M | $185M |
| EPS | $3.32 | $3.69 | $3.87 | $4.44 | $2.72 | $8.99 | $1.45 | $4.34 | $6.53 | $7.67 |
| BPS | $44.12 | $46.16 | $48.07 | $50.78 | $51.74 | $58.45 | $56.94 | $59.20 | $63.46 | $68.77 |
| ROE | 7.5% | 8.0% | 8.0% | 8.8% | 5.3% | 15.3% | 2.6% | 7.4% | 10.4% | 11.2% |